Compass Therapeutics, Inc. 8-K

What Happened

• Compass Therapeutics, Inc. (CMPX) filed a Form 8-K on May 5, 2026 to announce its financial results for the quarter ended March 31, 2026. The company issued a press release on that date summarizing the quarter’s results; that press release is furnished as Exhibit 99.1 and is incorporated by reference into the 8-K.

Key Details

• Filing date: May 5, 2026 (Form 8-K).
• Quarter covered: Quarter ended March 31, 2026 (Q1 2026).
• Disclosure: Press release announcing the quarterly results is furnished as Exhibit 99.1 to the 8-K.
• Item referenced: Item 2.02 (Results of Operations and Financial Condition); Exhibit listed under Item 9.01(d).

Why It Matters

• This 8-K provides Compass’ most recent public update on quarterly results—earnings, revenue, expenses, cash position, and any commentary presented in the press release. Retail investors should read the Exhibit 99.1 press release for the concrete figures and management commentary to assess the company’s near-term financial health and operational progress.